Thiopurine methyltransferase genotype distribution in patients with Crohn's disease

被引:28
作者
Reuther, LO [1 ]
Sonne, J
Larsen, N
Dahlerup, JF
Thomsen, OO
Schmiegelow, K
机构
[1] Gentofte Univ Hosp, Dept Clin Pharmacol, DK-2900 Hellerup, Denmark
[2] Glostrup Univ Hosp, Clin Pharmacol Lab, Glostrup, Denmark
[3] Arhus Univ Hosp, Dept Gastroenterol, Aarhus, Denmark
[4] Herlev Univ Hosp, Dept Gastroenterol, Herlev, Denmark
[5] Univ Hosp, Pediat Clin 2, Sect Pediat Hematol & Oncol, Copenhagen, Denmark
关键词
D O I
10.1046/j.1365-2036.2003.01403.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Inter-individual response to azathioprine is partly due to inter-individual variation in the thiopurine methyltransferase (TPMT) activity. The TPMT genotype, which reflects the TPMT activity, has previously been studied in healthy Caucasians, with the most common variant allele being TPMT*3A. TPMT genotyping in adult patients with Crohn's disease has never been performed systematically. Aim: To determine the TPMT genotype distribution in adult patients with Crohn's disease. Methods: One hundred and twenty randomly selected Danish patients (64 females and 56 males) with azathioprine-dependent Crohn's disease were included, and a polymerase chain reaction assay was used for TPMT genotyping. The patients were genotyped for the low-level genotype G460-->A and A719-->G transitions. Results: One hundred and nine patients (90.3%; 95% confidence interval, 84.1-95.3) had a wild-type/ wild-type genotype, whereas 10 patients (8.3%; 95% confidence interval, 4.1-14.8) had one non-functional mutant allele and one patient (0.8%; 95% confidence interval, 0.02-4.6) had two non-functional mutant alleles. Only the TPMT*3A variant allele was found. Conclusions: The study showed a TPMT genotype distribution amongst adult Danish patients with Crohn's disease which was similar to the distribution of TPMT variant alleles normally found in healthy Caucasians.
引用
收藏
页码:65 / 68
页数:4
相关论文
共 19 条
  • [1] A CONTROLLED DOUBLE-BLIND-STUDY OF AZATHIOPRINE IN THE MANAGEMENT OF CROHNS-DISEASE
    CANDY, S
    WRIGHT, J
    GERBER, M
    ADAMS, G
    GERIG, M
    GOODMAN, R
    [J]. GUT, 1995, 37 (05) : 674 - 678
  • [2] Genotypic analysis of thiopurine S-methyltransferase in patients with Crohn's disease and severe myelosuppression during azathioprine therapy
    Colombel, JF
    Ferrari, N
    Debuysere, H
    Marteau, P
    Gendre, JP
    Bonaz, B
    Soulé, JC
    Modgliani, R
    Touze, Y
    Catala, P
    Libersa, C
    Broly, F
    [J]. GASTROENTEROLOGY, 2000, 118 (06) : 1025 - 1030
  • [3] Corominas H, 2000, AM J GASTROENTEROL, V95, P2313
  • [4] The relationship between thiopurine methyltransferase activity and genotype in blasts from patients with acute leukemia
    Coulthard, SA
    Howell, C
    Robson, J
    Hall, AG
    [J]. BLOOD, 1998, 92 (08) : 2856 - 2862
  • [5] Review article: monitoring for drug side-effects in inflammatory bowel disease
    Cunliffe, RN
    Scott, BB
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2002, 16 (04) : 647 - 662
  • [6] Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease
    Dubinsky, MC
    Lamothe, S
    Yang, HY
    Targan, SR
    Sinnett, D
    Théorêt, Y
    Seidman, EG
    [J]. GASTROENTEROLOGY, 2000, 118 (04) : 705 - 713
  • [7] 6-MP metabolite profiles provide a biochemical explanation for 6-MP resistance in patients with inflammatory bowel disease
    Dubinsky, MC
    Yang, HY
    Hassard, PV
    Seidman, EG
    Kam, LY
    Abreu, MT
    Targan, SR
    Vasiliauskas, EA
    [J]. GASTROENTEROLOGY, 2002, 122 (04) : 904 - 915
  • [8] The efficacy of azathioprine for the treatment of inflammatory bowel disease: a 30 year review
    Fraser, AG
    Orchard, TR
    Jewell, DP
    [J]. GUT, 2002, 50 (04) : 485 - 489
  • [9] Genetic polymorphism of thiopurine S-methyltransferase: Clinical importance and molecular mechanisms
    Krynetski, EY
    Tai, HL
    Yates, CR
    Fessing, MY
    Loennechen, T
    Schuetz, JD
    Relling, MV
    Evans, WE
    [J]. PHARMACOGENETICS, 1996, 6 (04): : 279 - 290
  • [10] Pharmacogenetics as a molecular basis for individualized drug therapy: The thiopurine S-methyltransferase paradigm
    Krynetski, EY
    Evans, WE
    [J]. PHARMACEUTICAL RESEARCH, 1999, 16 (03) : 342 - 349